Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Kansai Startup Coalition Partners with Alloy Therapeutics to Boost Biotech Startups in Japan
Date 25 July 2025

Kansai Startup Coalition Partners with Alloy Therapeutics to Boost Biotech Startups in Japan

Kansai and Alloy are in a Collaboration to Leverage Growth in Japan Announcement Kansai Startup Academia Coalition, represented by Kyoto University, fostered to expansion university university-aff...

QIAGEN Launches QIAseq xHYB Long-Read Panels to Improve Genomic Research
Date 25 July 2025

QIAGEN Launches QIAseq xHYB Long-Read Panels to Improve Genomic Research

QIAGEN Enhances its Portfolio with Long-read Panels Announcement Qiagen has introduced new QIAseq xHYB long-read panels, a groundbreaking solution designed to explore the long-read sequencing of g...

Hengrui and IDEAYA Biosciences to Present Promising Lung Cancer Drug Data at IASLC 2025
Date 25 July 2025

Hengrui and IDEAYA Biosciences to Present Promising Lung Cancer Drug Data at IASLC 2025

Hengrui and IDEAYA Bioscience’s Publication for a Presentation at IASLC 2025 Announcement Jiangsu Hengrui Pharmaceuticals co ltd a pharmaceutical company known for its technological and scie...

AAVnerGene and Klotho Neurosciences Partner to Advance Gene Therapy for Neurological Diseases
Date 25 July 2025

AAVnerGene and Klotho Neurosciences Partner to Advance Gene Therapy for Neurological Diseases

AAVnerGene and Klotho’s Alliance Announcement AVVnerGene Inc., a Rockville, MD innovation-fueled biotech known for its remarkable technologies in AAV tissue-targeted delivery and manufacturi...

Cycle Pharmaceuticals and Handa Therapeutics Sign Sales Agreement for FDA-Approved Leukemia Drug PHYRAGO
Date 24 July 2025

Cycle Pharmaceuticals and Handa Therapeutics Sign Sales Agreement for FDA-Approved Leukemia Drug PHYRAGO

Cycle and Handa Signed an Exclusive Sales License Agreement Announcement Cycle Pharmaceuticals signed a us commercialization (sales) agreement with Handa Therapeutics LLC for PHYRAGO distribution ...

Sarepta Therapeutics Temporarily Stops ELEVIDYS Shipments to Address FDA Request
Date 24 July 2025

Sarepta Therapeutics Temporarily Stops ELEVIDYS Shipments to Address FDA Request

Sarepta Therapeutics Pauses ELEVIDYS Shipments in the US to Play a Vital Role Announcement Sarepta Therapeutics, Inc., a known producer of precision genetic medicine for rare diseases, decided to ...

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D by 2030
Date 24 July 2025

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D by 2030

AstraZeneca Intends to Invest in America Announcement AstraZeneca plans to invest approximately $50 billion in the United States by around 2030 to manufacture medicines and boost its research and ...

AusperBio Gets CDE Approval for Phase 3 Clinical Trial of Hepatitis B Drug AHB-137
Date 24 July 2025

AusperBio Gets CDE Approval for Phase 3 Clinical Trial of Hepatitis B Drug AHB-137

AusperBio Phase 3 Clinical Trial Approved by CDE Announcement Ausperbio Therapeutics Inc. and Ausper Biopharma Co., Ltd (merged Ausperbio), a biotechnology company known for the advancement in oli...

NKGen Biotech and HekaBio Partner to Launch New NK Cell Therapy in Japan
Date 23 July 2025

NKGen Biotech and HekaBio Partner to Launch New NK Cell Therapy in Japan

NKGen Biotech and HekaBio Came Together to Bring New NK Cell Therapy to Japan Announcement NKGen Biotech, a US-headquartered clinical-stage biotechnology company with a strong focus on the develop...

CoresteamChemo and ATG Lifetech Partner to Offer Advanced Preclinical CRO Services Worldwide
Date 23 July 2025

CoresteamChemo and ATG Lifetech Partner to Offer Advanced Preclinical CRO Services Worldwide

Korea’s CoresteamChemo & ATG Lifetech came Together to Expand the CRO’s Global Reach Partnership Overview A South Korea-based, leading GLP-certified preclinical CRO, CoresteamChemo...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.